TIDMDEMG
RNS Number : 7196Y
Deltex Medical Group PLC
23 August 2018
23 August 2018
Deltex Medical Group plc
("Deltex Medical" or the "Company")
Director Dealing
Deltex Medical Group plc (AIM: DEMG), the global leader in
Oesophageal Doppler Monitoring ("ODM"), was informed yesterday that
Nigel Keen, Chairman of the Company, purchased 2,000,000 ordinary
shares of 1 penny each in the Company ("Ordinary Shares") at a
price of 0.8 pence per Ordinary Share and 1,000,000 Ordinary Shares
at a price of 0.85 pence per Ordinary Share on 21 August 2018. On
22 August 2018, 1,000,000 Ordinary Shares at a price of 0.9 pence
per Ordinary Share were also purchased.
Following these transactions, Mr Keen's beneficial ownership is
52,223,410 Ordinary Shares, representing approximately 10.6 per
cent. of Deltex Medical's issued ordinary share capital.
Mr Keen also transferred 6,000,000 Ordinary Shares into the
Imperialise Limited Pension Fund on 23 August 2018. Mr Keen is the
principal beneficiary of this fund and following this transaction,
his beneficial interest in the Company remains unchanged from that
stated above.
For further information, please contact:-
Deltex Medical Group 01243 774 837
plc investorinfo@deltexmedical.com
Nigel Keen, Chairman
Andy Mears, Chief Executive
Jonathan Shaw, Group
Finance Director
Nominated Adviser &
Broker
Arden Partners plc 020 7614 5900
Chris Hardie
Ciaran Walsh
Joint Broker
Turner Pope Investments 0203 621 4120
(TPI) Ltd info@turnerpope.com
Andy Thacker
Financial Public Relations
IFC Advisory 0203 934 6630
Tim Metcalfe
Graham Herring
Heather Armstrong
Notes for Editors
Deltex Medical manufactures and markets haemodynamic monitoring
technologies. Deltex Medical's proprietary ODM (TrueVue(TM)
Doppler) is the only technology to measure blood flow in the
central circulation in real time. Minimally invasive, easy to set
up and quick to focus, the technology generates a low-frequency
ultrasound signal, which is highly sensitive to changes in flow and
measures them immediately. Deltex has been the only group in the
enhanced haemodynamic space to build a robust and credible evidence
base proving the clinical and economic benefits of its core
technology, TrueVue(TM) Doppler, which is proven to reduce
complications suffered by patients after surgery and save hospitals
the costs of treating those complications.
Deltex Medical's TrueVue(TM) System on the CardioQ-ODM+ monitor
platform also now provides clinicians with two further advanced
haemodynamic monitoring technologies. High Definition Impedance
Cardiography (TrueVue(TM) Impedance) is an entirely non-invasive
monitoring technology which creates an electrical field across the
chest and measures the disruption to this field when the heart
pumps blood. Pulse Pressure Waveform Analysis
(TrueVue(TM) Pressurewave) uses peripheral blood pressure signal
analysis to give doctors information on changes in the circulation
and is particularly suited to monitoring lower risk or
haemodynamically stable patients.
Group goal
Haemodynamic management is now becoming widely accepted as an
important major new medical modality. Consequently, the Group's
focus is on maximising value from the opportunities presented, as
enhanced haemodynamic management is adopted into routine clinical
practice around the world. The Group aims to provide clinicians
with a single platform, a 'haemodynamic workstation', which offers
them a range of technologies from simple to sophisticated to be
deployed according to the patient's condition as well as the skill
and expertise of the user. Doing this will enable the Group to
partner healthcare providers to support modern haemodynamic
management across the whole hospital.
The Group is currently in the implementation phase of achieving
this goal in a number of territories worldwide, operating directly
in the UK, USA, Spain and Canada and through distribution
arrangements in a further 30 countries.
Note: This announcement contains inside information for the
purposes of Article 7 of Regulation (EU) No 596/2014.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities ("PDMRs") and persons
closely associated with them.
Details of the person discharging managerial
1 responsibilities / person closely associated
---- ----------------------------------------------------------
a) Names Nigel Keen - Chairman
---- --------------------- -----------------------------------
2 Reason for the notification
---- ----------------------------------------------------------
a) Position/status See 1(a) above for position -
classified as a PDMR of Deltex
Medical
---- --------------------- -----------------------------------
b) Initial notification Initial
/Amendment
---- --------------------- -----------------------------------
3 Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
---- ----------------------------------------------------------
a) Name Deltex Medial Group plc
---- --------------------- -----------------------------------
b) LEI 213800XN34P6LI8J6M39
---- --------------------- -----------------------------------
4 Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
---- ----------------------------------------------------------
a) Description Ordinary shares of 1 penny each
of the financial ("Ordinary Shares")
instrument,
type of instrument
---- --------------------- -----------------------------------
b) Identification GB0059337583
code
---- --------------------- -----------------------------------
c) Nature of the Purchase of Ordinary Shares
transaction
---- --------------------- -----------------------------------
d) Price(s) and Prices(s) Volume(s)
volume(s) ----------- ----------
0.8 pence 2,000,000
----------- ----------
---- --------------------- -----------------------------------
d) Aggregated
information
- Aggregated
volume 2,000,000
- Price
0.8 pence
---- --------------------- -----------------------------------
e) Date of the
transaction 21 August 2018
---- --------------------- -----------------------------------
f) Place of the
transaction London Stock Exchange, AIM Market
(XLON)
---- --------------------- -----------------------------------
Details of the person discharging managerial
1 responsibilities / person closely associated
---- ----------------------------------------------------------
a) Names Nigel Keen - Chairman
---- --------------------- -----------------------------------
2 Reason for the notification
---- ----------------------------------------------------------
a) Position/status See 1(a) above for position -
classified as a PDMR of Deltex
Medical
---- --------------------- -----------------------------------
b) Initial notification Initial
/Amendment
---- --------------------- -----------------------------------
3 Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
---- ----------------------------------------------------------
a) Name Deltex Medial Group plc
---- --------------------- -----------------------------------
b) LEI 213800XN34P6LI8J6M39
---- --------------------- -----------------------------------
4 Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
---- ----------------------------------------------------------
a) Description Ordinary shares of 1 penny each
of the financial ("Ordinary Shares")
instrument,
type of instrument
---- --------------------- -----------------------------------
b) Identification GB0059337583
code
---- --------------------- -----------------------------------
c) Nature of the Purchase of Ordinary Shares
transaction
---- --------------------- -----------------------------------
d) Price(s) and Prices(s) Volume(s)
volume(s) ------------ ----------
0.85 pence 1,000,000
------------ ----------
---- --------------------- -----------------------------------
d) Aggregated
information
- Aggregated
volume 1,000,000
- Price
0.85 pence
---- --------------------- -----------------------------------
e) Date of the
transaction 21 August 2018
---- --------------------- -----------------------------------
f) Place of the
transaction London Stock Exchange, AIM Market
(XLON)
---- --------------------- -----------------------------------
Details of the person discharging managerial
1 responsibilities / person closely associated
---- ----------------------------------------------------------
a) Names Nigel Keen - Chairman
---- --------------------- -----------------------------------
2 Reason for the notification
---- ----------------------------------------------------------
a) Position/status See 1(a) above for position -
classified as a PDMR of Deltex
Medical
---- --------------------- -----------------------------------
b) Initial notification Initial
/Amendment
---- --------------------- -----------------------------------
3 Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
---- ----------------------------------------------------------
a) Name Deltex Medial Group plc
---- --------------------- -----------------------------------
b) LEI 213800XN34P6LI8J6M39
---- --------------------- -----------------------------------
4 Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
---- ----------------------------------------------------------
a) Description
of the financial
instrument, Ordinary shares of 1 penny each
type of instrument ("Ordinary Shares")
---- --------------------- -----------------------------------
b) Identification GB0059337583
code
---- --------------------- -----------------------------------
c) Nature of the
transaction Purchase of Ordinary Shares
---- --------------------- -----------------------------------
d) Price(s) and Prices(s) Volume(s)
volume(s) ----------- ----------
0.9 pence 1,000,000
----------- ----------
---- --------------------- -----------------------------------
d) Aggregated
information
- Aggregated
volume 1,000,000
- Price
0.9 pence
---- --------------------- -----------------------------------
e) Date of the
transaction 22 August 2018
---- --------------------- -----------------------------------
f) Place of the
transaction London Stock Exchange, AIM Market
(XLON)
---- --------------------- -----------------------------------
Details of the person discharging managerial
1 responsibilities / person closely associated
---- --------------------------------------------------------
a) Names Nigel Keen - Chairman
---- --------------------- ---------------------------------
2 Reason for the notification
---- --------------------------------------------------------
a) Position/status See 1(a) above for position -
classified as a PDMR of Deltex
Medical
---- --------------------- ---------------------------------
b) Initial notification Initial
/Amendment
---- --------------------- ---------------------------------
3 Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
---- --------------------------------------------------------
a) Name Deltex Medial Group plc
---- --------------------- ---------------------------------
b) LEI 213800XN34P6LI8J6M39
---- --------------------- ---------------------------------
4 Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
---- --------------------------------------------------------
a) Description
of the financial
instrument, Ordinary shares of 1 penny each
type of instrument ("Ordinary Shares")
---- --------------------- ---------------------------------
b) Identification GB0059337583
code
---- --------------------- ---------------------------------
c) Nature of the
transaction Share Transfer
---- --------------------- ---------------------------------
d) Price(s) and Prices(s) Volume(s)
volume(s) ----------- ----------
Nil 6,000,000
----------- ----------
---- --------------------- ---------------------------------
d) Aggregated
information
- Aggregated
volume 6,000,000
- Price
Nil
---- --------------------- ---------------------------------
e) Date of the
transaction 23 August 2018
---- --------------------- ---------------------------------
f) Place of the
transaction Off market transaction
---- --------------------- ---------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHLLFSLTSIVFIT
(END) Dow Jones Newswires
August 23, 2018 07:50 ET (11:50 GMT)
Deltex Medical (LSE:DEMG)
Historical Stock Chart
From Apr 2024 to May 2024
Deltex Medical (LSE:DEMG)
Historical Stock Chart
From May 2023 to May 2024